close
This essay has been submitted by a student. This is not an example of the work written by professional essay writers.

The Need for Standardizing Pre-analytical Sample Handling and Integrating Analytical Workflows for Ensuring Liquid Biopsies Are Ready for Prime-time

downloadDownload printPrint

Pssst… we can write an original essay just for you.

Any subject. Any type of essay.

We’ll even meet a 3-hour deadline.

Get your price

121 writers online

blank-ico
Download PDF

The dawn of cancer genomics has heralded an unprecedented era of precision medicine, allowing the identification of genome-wide somatic driver alterations that can be used for early cancer diagnosis, prognosis, stratification to optimum therapies and monitoring of developing resistance, as well as predicting which patients are likely to relapse. Currently, clinicians and translational researchers are utilising our vastly improved understanding of the heterogeneous molecular landscape of cancer to stratify patients appropriately to carefully selected targeted treatments with the aim of ensuring patients receive the right treatment at the right time.

Ultimately, there is hope that this will allow clinicians to either cure their patients disease (at the earliest stages) or manage their disease for the longest time possible, while still ensuring the highest possible quality of life (in advanced stages). The current “gold standard” for diagnosing cancer and determining optimal therapeutic strategies is through surgical biopsy. However, this method has several limitations, not least of all its invasiveness. Surgical biopsies are also extremely limited in that they only offer a “snapshot” in space and time of the tumour depending on the disease stage and local area. Further, they are known to be unrepresentative of tumour heterogeneity, potentially resulting in predominance of resistant clones that are refractory to therapy and eventually disease progression/therapy resistance.

Therefore, surgical biopsy cannot offer any indication of treatment efficacy and tumour evolution (especially in the metastatic setting) during a patient’s therapy. Compounding this, most biopsies are archived as formalin-fixed, paraffin embedded blocks that are used for routine pathology, necessitating highly-sensitive methods (such as next-generation sequencing (NGS) and digital polymerase chain reaction (dPCR)) for analysis of very limited amounts of poor quality nucleic acid. However, many of these limitations can be circumvented using liquid biopsies. The liquid biopsy holds huge potential as a more cost-effective, easier, less-invasive method for diagnosing and monitoring cancer, as well as predicting response to many currently available therapies. The liquid biopsy is used as an “umbrella” term that encompasses different analytes that can be identified in blood samples including: circulating tumour cells (CTCs), circulating free DNA (cfDNA), circulating tumour DNA (ctDNA – the tumour-derived fraction of cfDNA), circulating RNA (including circulating microRNA), extracellular vesicles such as exosomes and more recently, platelets (in particular tumour-educated platelets or TEPs) (REF).

Of these, CTCs and ctDNA are currently the most validated analytes and the most likely to translate into routine clinical use within the next 2-5 years due to their proven ability for early cancer diagnosis (REF), to dynamically monitor patient response to therapy (REF), to predict relapse (REF) and offer actionable somatic alterations for stratifying patients to the optimum therapies in real time (REFS). Overall, the liquid biopsy can complement a personalised medicine approach to cancer treatment as well as providing innovative methods towards patient selection in clinical trials. However, despite the huge potential of the liquid biopsy for managing patient therapy, several technical and logistical challenges need to be overcome before it can be truly integrated into routine clinical use.

Of note, there is still no widely accepted consensus regarding pre-analytical blood sample handling, technologies used for extracting cfDNA and CTCs, as well as no routinely used robust and reproducible workflow towards consistent molecular analysis of liquid biopsy analytes – both of which are urgently needed before liquid biopsies can become routinely used in the clinic.

infoRemember: This is just a sample from a fellow student.

Your time is important. Let us write you an essay from scratch

100% plagiarism-free

Sources and citations are provided

Find Free Essays

We provide you with original essay samples, perfect formatting and styling

Cite this Essay

To export a reference to this article please select a referencing style below:

Standardizing Pre-Analytical Sample Handling. (2020, April 12). GradesFixer. Retrieved July 29, 2021, from https://gradesfixer.com/free-essay-examples/the-need-for-standardizing-pre-analytical-sample-handling-and-integrating-analytical-workflows-for-ensuring-liquid-biopsies-are-ready-for-prime-time/
“Standardizing Pre-Analytical Sample Handling.” GradesFixer, 12 Apr. 2020, gradesfixer.com/free-essay-examples/the-need-for-standardizing-pre-analytical-sample-handling-and-integrating-analytical-workflows-for-ensuring-liquid-biopsies-are-ready-for-prime-time/
Standardizing Pre-Analytical Sample Handling. [online]. Available at: <https://gradesfixer.com/free-essay-examples/the-need-for-standardizing-pre-analytical-sample-handling-and-integrating-analytical-workflows-for-ensuring-liquid-biopsies-are-ready-for-prime-time/> [Accessed 29 Jul. 2021].
Standardizing Pre-Analytical Sample Handling [Internet]. GradesFixer. 2020 Apr 12 [cited 2021 Jul 29]. Available from: https://gradesfixer.com/free-essay-examples/the-need-for-standardizing-pre-analytical-sample-handling-and-integrating-analytical-workflows-for-ensuring-liquid-biopsies-are-ready-for-prime-time/
copy to clipboard
close

Sorry, copying is not allowed on our website. If you’d like this or any other sample, we’ll happily email it to you.

    By clicking “Send”, you agree to our Terms of service and Privacy statement. We will occasionally send you account related emails.

    close

    Attention! This essay is not unique. You can get a 100% Plagiarism-FREE one in 30 sec

    Receive a 100% plagiarism-free essay on your email just for $4.99
    get unique paper
    *Public papers are open and may contain not unique content
    download public sample
    close

    Sorry, we could not paraphrase this essay. Our professional writers can rewrite it and get you a unique paper.

    close

    Thanks!

    Your essay sample has been sent.

    Want us to write one just for you? We can custom edit this essay into an original, 100% plagiarism free essay.

    thanks-icon Order now
    boy

    Hi there!

    Are you interested in getting a customized paper?

    Check it out!
    Having trouble finding the perfect essay? We’ve got you covered. Hire a writer
    exit-popup-close

    Haven't found the right essay?

    Get an expert to write you the one you need!

    exit-popup-print

    Professional writers and researchers

    exit-popup-quotes

    Sources and citation are provided

    exit-popup-clock

    3 hour delivery

    exit-popup-persone